
1. methods mol biol. 2019;2013:123-140. doi: 10.1007/978-1-4939-9550-9_9.

plasmodium falciparum vitro drug resistance selections gene editing.

ng cl(1), fidock da(2)(3).

author information: 
(1)department pathology microbiology, university nebraska medical
center, omaha, ne, usa.
(2)department microbiology immunology, columbia university irving medical 
center, new york, ny, usa. df2260@cumc.columbia.edu.
(3)division infectious diseases, department medicine, columbia university
irving medical center, new york, ny, usa. df2260@cumc.columbia.edu.

malaria continues global health burden, threatening 40% the
world's population. drug resistance plasmodium falciparum, etiological
agent majority human malaria cases, compromising elimination
efforts. new approaches treating drug-resistant malaria benefit defining 
resistance liabilities known antimalarial agents compounds development 
and defining genetic changes mediate loss parasite susceptibility. here, 
we present protocols vitro selection drug-resistant parasites for
site-directed gene editing candidate resistance mediators test for
causality.

doi: 10.1007/978-1-4939-9550-9_9 
pmcid: pmc6756925
pmid: 31267498  [indexed medline]

